MDA
Healio brings you the highlights from Muscular Dystrophy Association Clinical & Scientific Conference. Refer back to this page often for the latest news from MDA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
expand
SPONSORED CONTENT
March 26, 2025
1 min read
Save
No clear benefit to losmapimod for facioscapulohumeral muscular dystrophy
Treatment with losmapimod resulted in no clear benefit compared with placebo in individuals with facioscapulohumeral muscular dystrophy at 48 weeks, according to research presented at the Muscular Dystrophy Association Clinical & Scientific Conference.